Deliverables

D4.9 Work Package 4 White Paper: methods for vaccine benefit-risk monitoring, including vaccine coverage, safety and effectiveness

EXECUTIVE SUMMARY: The content of this white paper focuses on post-licensure BRA methodology carried out in Work Package 4 (WP4) of the IMI project Accelerated development of vaccine benefit-risk collaboration in Europe - ADVANCE. Its starting...

descargar documentación
or

D3.5 White paper: procedures for data access, sharing, linkage and integration, including privacy and ethics

EXECUTIVE SUMMARY: The aims of ADVANCE WP3 are to: identify data sources across Europe that can be used for comprehensive, rapid vaccine benefit-risk monitoring; catalogue and describe data sources and their relevance for vaccine benefit-risk...

descargar documentación
or

D4.4 Report on tested methods for accelerated assessment of vaccination coverage...

EXECUTIVE SUMMARY: The ADVANCE vision is to deliver the “best evidence at the right time to support decision-making on vaccination in Europe”. The mission is to establish a prototype of a sustainable and compelling system that rapidly...

descargar documentación
or

D3.4 Catalogue and meta-profiles of data sources for vaccine benefit-risk monitoring

Overview of the AIRR instrument - The ADVANCE work package has been tasked to identify data sources in Europe that can potentially contribute to vaccine benefit-risk studies. In the process of achieving this aim, we developed the AIRR (ADVANCE...

descargar documentación
or

D3.3 Final Report on the Technical Requirements Analysis

Introduction - Work Package 3 (WP3) of the Accelerated Development of VAccine benefit-risk Collaboration in Europe (ADVANCE) consortium is the WP involved with how to identify data sources for the rapid and integrated monitoring of benefit-risk...

descargar documentación
or

D 1.9 - Good Practice Guidance – Modules 1 and 3: Code of Conduct and Quality recommendations

EXECUTIVE SUMMARY Effective collaboration between stakeholders and governance for the conduct of studies are among the main objectives of ADVANCE. In this context, Work Package 1 will deliver a good practice guidance including core values to be...

descargar documentación
or

Deliverable 1.7: Analysis of key issues and gaps about perception and knowledge on benefits and risks of vaccines

EXECUTIVE SUMMARY As part of the IMI-ADVANCE project, a “Strategy for public communication in the context of vaccine benefit-risk monitoring” is to be developed (deliverable D.1.12.).A key element for the development of...

descargar documentación
or

D1.10 Final conceptual model for public-private interaction (“Good Practice Guidance Module 2: Governance models.”).

EXECUTIVE SUMMARY: The pandemic influenza season and the new pharmacovigilance legislation have changed the paradigm in Europe on how vaccines should be monitored in post marketing settings and how public and private stakeholders should interact to...

descargar documentación
or

D5.3 POC Research plan

EXECUTIVE SUMMARY: The POC Research plan is aimed to provide an overview of the procedures that guide the first round of proof of concept studies.

descargar documentación
or